These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers. Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765 [TBL] [Abstract][Full Text] [Related]
4. Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection. Henneges C; Bullinger D; Fux R; Friese N; Seeger H; Neubauer H; Laufer S; Gleiter CH; Schwab M; Zell A; Kammerer B BMC Cancer; 2009 Apr; 9():104. PubMed ID: 19344524 [TBL] [Abstract][Full Text] [Related]
5. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process. Tebib JG; Reynaud C; Cedoz JP; Letroublon MC; Niveleau A Br J Rheumatol; 1997 Sep; 36(9):990-5. PubMed ID: 9376997 [TBL] [Abstract][Full Text] [Related]
6. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese. Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. Cho SH; Choi MH; Lee WY; Chung BC Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer. Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242 [TBL] [Abstract][Full Text] [Related]
9. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine. Waalkes TP; Dinsmore SR; Mrochek JE J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877 [No Abstract] [Full Text] [Related]
11. Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling. Kammerer B; Frickenschmidt A; Müller CE; Laufer S; Gleiter CH; Liebich H Anal Bioanal Chem; 2005 Jun; 382(4):1017-26. PubMed ID: 15906010 [TBL] [Abstract][Full Text] [Related]
12. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition. Mao Y; Zhao X; Wang S; Cheng Y Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304 [TBL] [Abstract][Full Text] [Related]
13. [Excretion of methylated nucleosides in the initial therapy phase in a case of anorexia nervosa]. Clemens P; Schöch G; Ziemer G; Altenhoff J; Erb N; Lorenz H; Müller J; Grüttner R Padiatr Padol; 1982; 17(2):157-63. PubMed ID: 7099674 [TBL] [Abstract][Full Text] [Related]
14. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043 [TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of six modified nucleosides by patients with breast carcinoma. Vreken P; Tavenier P Ann Clin Biochem; 1987 Nov; 24 ( Pt 6)():598-603. PubMed ID: 3426126 [TBL] [Abstract][Full Text] [Related]
16. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract. Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364 [TBL] [Abstract][Full Text] [Related]
17. Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling. Bullinger D; Neubauer H; Fehm T; Laufer S; Gleiter CH; Kammerer B BMC Biochem; 2007 Nov; 8():25. PubMed ID: 18047657 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients. Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313 [TBL] [Abstract][Full Text] [Related]
19. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis. Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767 [TBL] [Abstract][Full Text] [Related]
20. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Xu G; Schmid HR; Lu X; Liebich HM; Lu P Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]